Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Insulin, Glulisine, Human (Apidra)

Also known as Apidra

Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than human insulin. When used as a meal time insulin, the dose is given within 15 minutes before a meal or within 20 minutes after starting a meal. Intravenous injections may also be used for extreme hyperglycemia, but must be performed under the supervision of a medical professional.

Source: Wikipedia

Estimated Total Cost: $170.43 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed insulin, glulisine, human to treat diabetes, chronic ulcer, blastomycosis, and rabies.

Ajax-loader Loading...